Publication | Open Access
Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia
74
Citations
36
References
2017
Year
Novartis Institutes for BioMedical Research, Basel, Switzerland.
| Year | Citations | |
|---|---|---|
Page 1
Page 1